Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery.
The aim of the present work was to develop a new nanoparticle carrier, adapted for the oral administration of proteins and their delivery to the immune system. Chitosan and phosphorylated glucomannan were chosen as major constituents of the nanoparticles. Chitosan nanoparticles were formed by ionic gelation and then coated with glucomannan. Two different protocols were adopted for the formation of the glucomannan coating: protocol I, in which chitosan nanoparticles were isolated before their coating; protocol II, in which chitosan nanoparticles were not isolated, but coated with glucomannan in the presence of free chitosan. The results showed that, under the selected formulation conditions, the sizes of the nanoparticles ranged between 170 and 300 nm and their zeta potential values were inverted from positive to negative by the glucomannan coating. The nanoparticles prepared by the two protocols could be freeze-dried, in the presence or absence of cryoprotective agents, preserving their original characteristics. The results of the stability study evidenced the positive role of the glucomannan coating in preventing the aggregation of the nanoparticles in buffered media. Finally, the association of the inmunomodulatory protein complex P1 to the chitosan-glucomannan nanoparticles was investigated. The results showed that the association was not dependent on the chitosan: sodium tripoliphosphate ratio, but it was significantly affected by the presence of sodium phosphate in the protein structure.
Cuña
M
M
Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Spain.
Alonso-Sandel
M
M
Remuñán-López
C
C
Pivel
J P
JP
Alonso-Lebrero
J L
JL
Alonso
M J
MJ
D048271:Chitosan / Q000737:chemistry*; D020099:Coated Materials, Biocompatible / Q000737:chemistry; D003460:Crystallization / Q000379:methods*; D004337:Drug Carriers / Q000737:chemistry*; D046911:Macromolecular Substances; D008351:Mannans / Q000737:chemistry*; D008422:Materials Testing; D008968:Molecular Conformation; D049329:Nanostructures / Q000737:chemistry* / Q000648:ultrastructure; D036103:Nanotechnology / Q000379:methods; D010316:Particle Size; D010766:Phosphorylation; D011506:Proteins / Q000008:administration & dosage* / Q000737:chemistry*; D013499:Surface Properties
D020099:Coated Materials, Biocompatible; D004337:Drug Carriers; D046911:Macromolecular Substances; D008351:Mannans; D011506:Proteins; C022901:(1-6)-alpha-glucomannan; D048271:Chitosan